Literature DB >> 7684679

Enhancement of in vitro bactericidal activity of neutrophils from trauma patients in the presence of granulocyte colony-stimulating factor.

K Anding1, A Kropec, E Schmidt-Eisenlohr, A Benzing, K Geiger, F Daschner.   

Abstract

In order to determine whether granulocyte colony-stimulating factor (G-CSF) can enhance the bactericidal activity of polymorphonuclear leukocytes (PMNL) in trauma patients, PMNL obtained from severely injured patients one or two days after trauma were incubated with G-CSF and Staphylococcus aureus for different periods of time. G-CSF at a concentration of 6000 units/ml significantly improved the antibacterial activity of PMNL in trauma patients (n = 10) and healthy volunteers (n = 12) during the incubation period of 180 min. No difference in the bactericidal function of PMNL could be found between severely injured patients and healthy donors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684679     DOI: 10.1007/bf01967588

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice.

Authors:  H Yasuda; Y Ajiki; T Shimozato; M Kasahara; H Kawada; M Iwata; K Shimizu
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

4.  The immune consequences of trauma.

Authors:  S E Miller; C L Miller; D D Trunkey
Journal:  Surg Clin North Am       Date:  1982-02       Impact factor: 2.741

5.  Effect of azlocillin and piperacillin in subinhibitory and inhibitory concentrations on Staphylococcus aureus and Pseudomonas aeruginosa in broth, in serum and in the presence of human polymorphonuclear leukocytes.

Authors:  M Bassler; W Depuis; E Utz; H M Just; F D Daschner
Journal:  Eur J Clin Microbiol       Date:  1983-10       Impact factor: 3.267

6.  Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide.

Authors:  S Kitagawa; A Yuo; L M Souza; M Saito; Y Miura; F Takaku
Journal:  Biochem Biophys Res Commun       Date:  1987-05-14       Impact factor: 3.575

7.  Depression of cellular immunity after multiple trauma in the absence of sepsis.

Authors:  J B O'Mahony; S B Palder; J J Wood; A McIrvine; M L Rodrick; R H Demling; J A Mannick
Journal:  J Trauma       Date:  1984-10

8.  Neutrophil function in surgical patients. Relationship to adequate bacterial defenses.

Authors:  V Buffone; J L Meakins; N V Christou
Journal:  Arch Surg       Date:  1984-01

9.  Polymorphonuclear leukocyte migration abnormalities and their significance in seriously traumatized patients.

Authors:  E G Maderazo; S D Albano; C L Woronick; A D Drezner; R Quercia
Journal:  Ann Surg       Date:  1983-12       Impact factor: 12.969

10.  The capacity of serum to support neutrophil phagocytosis is a vital host defense mechanism in severely injured patients.

Authors:  H C Polk; C D George; M J Hershman; S R Wellhausen; W G Cheadle
Journal:  Ann Surg       Date:  1988-06       Impact factor: 12.969

View more
  3 in total

1.  Bactericidal activity response of blood neutrophils from critically ill patients to in vitro granulocyte colony-stimulating factor stimulation.

Authors:  Kun Yang; Elie Azoulay; Lynda Attalah; Jean-Ralph Zahar; Andry Van de Louw; Charles Cerf; Claude-James Soussy; Philippe Duvaldestin; Laurent Brochard; Christian Brun-Buisson; Alain Harf; Christophe Delclaux
Journal:  Intensive Care Med       Date:  2003-01-23       Impact factor: 17.440

2.  Synergy of simultaneous administration of ofloxacin and granulocyte colony-stimulating factor in killing of Escherichia coli by human neutrophils.

Authors:  A Kropec; S W Lemmen; H J Grundmann; I Engels; F D Daschner
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

3.  Combined effect of human neutrophils, ceftazidime and granulocyte colony-stimulating factor on killing of Escherichia coli.

Authors:  F D Daschner; H Grundmann; K Anding; S Lemmen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.